President Obama July 22 signed into law the Comprehensive Addiction and Recovery Act, S. 524, legislation designed to help stem the epidemic of opioid abuse through education, prevention, treatment and rehabilitation.

In a rare instance of consensus in Congress, the Senate July 13 voted 92-2 to approve the conference report to the legislation. The House passed the conference report on July 8, and President Obama is expected to sign it into law.

S. 524 incorporates several key AHA-endorsed measures, including the creation of a multi-agency task force with a hospital representative that will develop best practices for prescribing and pain management; more stringent pre-market review of new opioids by the Food and Drug Administration; increased access to opioid overdose reversal drugs and medication-assisted treatment; and expanded research and treatment for vulnerable populations.

The legislation would create a pilot program to support family-based services for pregnant and postpartum women with a primary diagnosis of a substance use disorder, including opioid use disorders. It also would authorize multiyear funding for the Department of Justice to issue grants to states, local governments and Indian tribes to be used to develop or expand treatment alternatives to incarceration programs, and train law enforcement officers and other first responders in the use of naloxone to reverse an opioid overdose.

Among other provisions, the legislation would create training programs for providers to test co-prescription for at-risk patients; raise awareness and education around the safe care of infants born affected by illegal substances; and require the Government Accountability Office to track and report on the capacity for inpatient and outpatient treatment for opioid abuse disorders. 

AHA members July 14 received a Special Bulletin with more on the legislation, as well as recent actions by the administration and AHA to combat the opioid abuse epidemic.

Opioid abuse and addiction led to more than 28,000 American deaths in 2014, according to the Centers for Disease Control and Prevention.

 

Related News Articles

Headline
The AHA Sept. 15 expressed support for the Ensuring Access to Essential Providers Act, legislation that would require Medicare Advantage plans to cover…
Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
The House Energy and Commerce Subcommittee on Health Sept. 10 advanced the Title VIII Nursing Workforce Reauthorization Act (H.R. 3593), AHA-supported…
Headline
The House Appropriations Committee Sept. 9 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services, Education…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The AHA Sept. 4 expressed support for the Hospitals As Naloxone Distribution Sites Act (H.R. 5120), legislation that would require Medicare and Medicaid to…